Susquehanna International Group, LLP Cabaletta Bio, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$3.94 - $8.24 $206,850 - $432,600	52,500 Added 272.02%	71,800 $338,000
Q2 2024 Aug 15, 2024	SELL	$7.22 - $18.82 $104,690 - $272,890	-14,500 Reduced 42.9%	19,300 $144,000
Q1 2024 May 07, 2024	BUY	$16.79 - $25.38 $183,011 - $276,642	10,900 Added 47.6%	33,800 $576,000
Q4 2023 Feb 14, 2024	SELL	$12.21 - $23.36 $170,940 - $327,040	-14,000 Reduced 37.94%	22,900 $519,000
Q3 2023 Nov 14, 2023	BUY	$11.84 - $18.65 $101,824 - $160,390	8,600 Added 30.39%	36,900 $561,000
Q2 2023 Aug 11, 2023	BUY	$7.65 - $13.95 $216,495 - $394,785	28,300 New	28,300 $365,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.